HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Familiar glioblastoma presenting as a true multicentric tumor: etiopathogenic and prognostic features].

Abstract
Familial glioblastoma multiforme is a rather uncommon entity, being in most cases associated to known genetic disorders (as Turcot syndrome, Li-Fraumeni syndrome, neurofibromatosis, etc.). However, familial gliomas have also been described, although less frequently, independently of these genetic syndromes showing some special features regarding its etiology and clinical manifestations. Less than 10% of gliomas may be considered as true multicentric tumours either synchronous or metachronous in clinical presentation. Metachronous glioblastomas have been associated to better prognosis in some studies, with genetic studies having found clear differences among the tumors within same patients. Familial glioblastoma with metachronous presentation is an exceptional disorder. These tumors show special therapeutic implications due to the limitations of radiotherapy once the patient has already irradiated. A variety of non-specific mutations have been found in these patients but true characterization of this disorder remains unclear and will be based on further genetic studies. We present a clinical report on a patient harbouring a familial and metachronous glioblastoma. The main aspects of this entity are reviewed.
AuthorsB Iza, O Mateo-Sierra, F Ruiz-Juretszke, J Garbizu, J Guzmán de Villoria, R Carrillo
JournalNeurocirugia (Asturias, Spain) (Neurocirugia (Astur)) Vol. 17 Issue 4 Pg. 340-6; discussion 346-7 (Aug 2006) ISSN: 1130-1473 [Print] Spain
Vernacular TitleGlioblastoma familiar múltiple de aparición metácrona: implicaciones etiopatogénicas y pronósticas.
PMID16960645 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Brain Neoplasms (diagnosis, pathology, physiopathology, surgery)
  • Fatal Outcome
  • Female
  • Glioblastoma (diagnosis, pathology, physiopathology, surgery)
  • Humans
  • Middle Aged
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: